Skip to search formSkip to main contentSkip to account menu

Bowman-Birk inhibitor concentrate

Known as: BBIC, Bowman Birk inhibitor concentrate, Proteinase Inhibitor, Bowman-Birk Soybean 
An extract of soybeans enriched in Bowman-Birk inhibitor (BBI), a soybean-derived, 71-amino acid, polypeptide and serine protease inhibitor with… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
An integrated 60GHz low power two-chip wireless system based on IEEE802.11ad standard
This paper presents our developed two-chip wireless communication system adhering to the IEEE 802.11ad standards with a baseband… 
2008
2008
Effects of a single-dose administration of Bowman-Birk inhibitor concentrate on anti-proliferation and inhabitation of metastasis in M5076 ovarian sarcoma-bearing mice.
The present study was designed to investigate the effects of Bowman-Birk inhibitor concentrate (BBIC) on anti-proliferation, up… 
Highly Cited
2007
Highly Cited
2007
Bowman-Birk inhibitor concentrate prevents atrophy, weakness, and oxidative stress in soleus muscle of hindlimb-unloaded mice.
Antigravity muscles atrophy and weaken during prolonged mechanical unloading caused by bed rest or spaceflight. Unloading also… 
Review
2006
Review
2006
12 The Status of Human Trials Utilizing Bowman-Birk Inhibitor Concentrate from Soybeans
The soybean-derived protease inhibitor known as the Bowman‐Birk inhibitor (BBI) has many preventive and therapeutic effects for… 
2005
2005
Selective Radioprotection of Normal Tissues by Bowman-Birk Proteinase Inhibitor (BBI) in Mice
Background and Purpose:The efficacy of radiotherapy is limited by the response of normal tissues within the radiation field. The… 
Review
2003
Review
2003
Development of the Bowman‐Birk inhibitor for oral cancer chemoprevention and analysis of neu immunohistochemical staining intensity with Bowman‐Birk inhibitor concentrate treatment
Objectives/Hypothesis: Cancer chemoprevention is a rapidly evolving approach to reverse or inhibit carcinogenesis, and there is… 
2002
2002
Detection of Bowman-Birk Inhibitor and Anti-Bowman-Birk Inhibitor Antibodies in Sera of Humans and Animals Treated With Bowman-Birk Inhibitor Concentrate
The Bowman-Birk inhibitor (BBI) is a soybean-derived serine protease inhibitor with anticarcinogenic activities. BBI, in the form… 
1998
1998
Growth inhibition and cytotoxicity induced by Bowman-Birk inhibitor concentrate in cisplatin-resistant human ovarian cancer cells.
Bowman-Birk inhibitor (BBI) is a soybean-derived anticarcinogenic protease inhibitor that was shown to potentiate the… 
1996
1996
Effects of the Bowman-Birk protease inhibitor on survival of fibroblasts and cancer cells exposed to radiation and cis-platinum.
The Bowman-Birk inhibitor (BBI) is a soybean-derived anticarcinogenic protease inhibitor with anti-inflammatory activity. To… 
1993
1993
Cationized Bowman-Birk protease inhibitor as a targeted cancer chemopreventive agent.
The conjugate of the Bowman-Birk inhibitor (BBI) with poly(D-lysine) (PDL-ss-BBI) has been suggested as a lung-targeted anti… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)